Proliferation potential and histological features in neurofibromatosis 2-associated and sporadic meningiomas

Journal of Neurosurgery

Volumn 87, Issue 4, 1997, Pages 610-614

  Antinheimo, Jussi ^a   Haapasalo, Hannu ^b   Haltia, Matti ^b   Tatagiba, Marcos ^b   Thomas, Sebastian ^b   Brandis, Almuth ^b   Sainio, Markku ^b   Carpen, Olli ^b   Samii, Madjid ^b   Jääskeläinen, Juha ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NONE

Author keywords

Ki 67; Meningioma; MIB 1; Neurofibromatosis 2; Proliferation potential

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CELL NUCLEUS; CELL PROLIFERATION; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MENINGIOMA; MITOSIS; MOLECULAR BIOLOGY; NEUROFIBROMATOSIS; PRIORITY JOURNAL;

EID: 0030883541     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.1997.87.4.0610     Document Type: Article

References (33)

1. Aguiar PH, Tatagiba M, Samii M, et al: The comparison between the growth fraction of bilateral vestibular schwannomas in neurofibromatosis 2 (NF2) and unilateral vestibular schwannomas using the monoclonal antibody MIB 1. Acta Neurochir 134:40-45, 1995
2. Antinheimo J, Haapasalo H, Seppälä M, et al: Proliferative potential of sporadic and neurofibromatosis 2-associated schwannomas as studied by MIB-1 (Ki-67) and PCNA labeling. J Neuropathol Exp Neurol 54:776-782, 1995
3. Bourn D, Carter SA, Evans DGR, et al: A mutation in the neurofibromatosis 2 tumor-suppressor gene, giving rise to widely different clinical phenotypes in two unrelated individuals. Am J Hum Genet 55:69-73, 1994
4. Cattoretti G, Becker MHG, Key G: Monoclonal antibodies against recombinant parts of the Ki -67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 168:357-363, 1992
5. De Vitis LR, Tedde A, Vitelli F, et al: Screening for mutations in the neurofibromatosis type 2 (NF2) gene in sporadic meningiomas. Hum Genet 97:632-637, 1996
6. Deen HG Jr, Scheithauer BW, Ebersold MJ: Clinical and pathological study of meningiomas of the first two decades of life. J Neurosurg 56:317-322, 1982
7. Evans DGR, Blair V, Strachan T, et al: Variation of expression of the gene for type 2 neurofibromatosis: absence of a gender effect on vestibular schwannomas, but confirmation of a preponderance of meningiomas in females. J Laryngol Otol 109: 830-835, 1995
8. Evans DGR Huson SM, Donnai D et al: A clinical study of type 2 neurofibromatosis. Q J Med 84:603-618, 1992
9. Jääskeläinen J, Haltia M, Servo M: Atypical and anaplastic meningiomas: radiology, surgery, radiotherapy, and outcome. Surg Neurol 25:233-242, 1986
10. Jääskeläinen J, Paetau A, Pyykkö I, et al: Interface between the facial nerve and large acoustic neurinomas. Immunohistochemical study of the cleavage plane in NF2 and non-NF2 cases. J Neurosurg 80:541-547, 1994
11. Jellinger K, Slowik F: Histological subtypes and prognostic problems in meningiomas. J Neurol 208:279-298, 1975
12. Karamitopoulou E, Perentes E, Diamantis I, et al: Ki-67 immunoreactivity in human central nervous system tumors: a study with MIB 1 monoclonal antibody on archival material. Acta Neuropathol 87:47-54, 1994
13. Kleihues P, Burger PC, Scheithauer BW: Histological Typing of Tumours of the Central Nervous System, ed 2. New York: Springer-Verlag, 1993, pp 33-42
14. Kolles H, Niedermayer I, Schmitt C, et al: Triple approach for diagnosis and grading of meningiomas: histology, morphometry of Ki-67/feulgen stainings, and cytogenetics. Acta Neurochir 137:174-181, 1995
15. Lekanne Deprez RH, Bianchi AB, Groen NA, et al: Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas. Am J Hum Genet 54:1022-1029, 1994
16. Louis DN, Ramesh V, Gusella JF: Neuropathology and molecular genetics of neurofibromatosis 2 and related tumors. Brain Pathol 5:163-172, 1995
17. Mautner VF, Lindenau M, Baser ME, et al: The neuroimaging and clinical spectrum of neurofibromatosis 2. Neurosurgery 38:880-886, 1996
18. Mérel P, Hoang-Xuan K, Sanson M, et al: Screening for germline mutations in the NF2 gene. Genes Chromosom Cancer 12:117-127, 1995
19. Nagashima O, Aoyagi M, Wakimoto H, et al: Immunohistochemical detection of progesterone receptors and the correlation with Ki-67 labeling indices in paraffin-embedded sections of meningiomas. Neurosurgery 37:478-483, 1995
20. Nakasu S, Nakajima M, Matsumura K, et al: Meningioma: proliferating potential and clinicoradiological features. Neurosurgery 37:1049-1055, 1995
21. National Institutes of Health Consensus Development Conference: Neurofibromatosis 1 (Recklinghausen disease) and neurofibromatosis 2 (bilateral acoustic neurofibromatosis). An update. Ann Intern Med 113:39-52, 1990
22. Ng H, Lau K, Tse JYM, et al: Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors. Neurosurgery 37: 764-773, 1995
23. Parry DM, Eldridge R, Kaiser-Kupfer MI, et al: Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity. Am J Med Genet 52:450-461, 1994
24. Peyrard M, Fransson I, Xie YG, et al: Characterization of a new member of the human beta-adaptin gene family from chromosome 22q12, a candidate meningioma gene. Hum Mol Genet 3:1393-1399, 1994
25. Rohringer M, Sutherland GR, Louw DF, et al: Incidence and clinicopathological features of meningioma. J Neurosurg 71: 665-672, 1989
26. Rouleau GA, Merel P, Lutchman M, et al: Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 363:515-521, 1993
27. Ruttledge MH, Andermann AA, Phelan CM, et al: Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease. Am J Hum Genet 59: 331-342, 1996
28. Ruttledge MH, Sarrazin J, Rangaratnam S, et al: Evidence of complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nat Genet 6:180-184, 1994
29. Seppälä MT, Haltia MJ, Sankila RJ, et al: Long-term outcome after removal of spinal schwannoma: a clinicopathological study of 187 cases. J Neurosurg 83:621-626, 1995
30. Simon M, von Deimling A, Larson JJ, et al: Allelic losses on chromosome 14, 10, and 1 in atypical and malignant meningiomas: a genetic model of meningioma progression. Cancer Res 55:4696-4701, 1995
31. Sobel RA: Vestibular (acoustic) schwannomas: histologic features in neurofibromatosis 2 and unilateral cases. J Neuropathol Exp Neurol 52:106-113, 1993
32. Trofatter JA, MacCollin MM, Rutter JL, et al: A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 72:791-800, 1993
33. Wellenreuther R, Kraus JA, Lenartz D, et al: Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningiomas. Am J Pathol 146:827-832, 1995